Your browser doesn't support javascript.
loading
Reducing the global burden of cerebral venous thrombosis: An international research agenda.
Coutinho, Jonathan M; van de Munckhof, Anita; Aguiar de Sousa, Diana; Poli, Sven; Aaron, Sanjith; Arauz, Antonio; Conforto, Adriana B; Krzywicka, Katarzyna; Hiltunen, Sini; Lindgren, Erik; Sánchez van Kammen, Mayte; Shu, Liqi; Bakchoul, Tamam; Belder, Rosalie; van den Berg, René; Boumans, Elisheva; Cannegieter, Suzanne; Cano-Nigenda, Vanessa; Field, Thalia S; Fragata, Isabel; Heldner, Mirjam R; Hernández-Pérez, María; Klok, Frederikus A; Leker, Ronen R; Lucas-Neto, Lia; Molad, Jeremy; Nguyen, Thanh N; Saaltink, Dirk-Jan; Saposnik, Gustavo; Sharma, Pankaj; Stam, Jan; Thijs, Vincent; van der Vaart, Michiel; Werring, David J; Wong Ramos, Diana; Yaghi, Shadi; Yesilot, Nilüfer; Tatlisumak, Turgut; Putaala, Jukka; Jood, Katarina; Arnold, Marcel; Ferro, José M.
Affiliation
  • Coutinho JM; Department of Neurology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
  • van de Munckhof A; Department of Neurology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
  • Aguiar de Sousa D; Stroke Center, Centro Hospitalar Universitário Lisboa Central, Institute of Anatomy, Faculdade de Medicina, Universidade de Lisboa, and L Lopes Lab, Instituto de Medicina Molecular JLA, Lisbon, Portugal.
  • Poli S; Department of Neurology & Stroke, University of Tübingen, Tübingen, Germany.
  • Aaron S; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Arauz A; Christian Medical College Hospital, Vellore, India.
  • Conforto AB; Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico.
  • Krzywicka K; LIM-44, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Hiltunen S; Department of Neurology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
  • Lindgren E; Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Sánchez van Kammen M; Department of Neurology, Sahlgrenska University Hospital and Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Shu L; Department of Neurology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
  • Bakchoul T; Brown University, Providence, RI, USA.
  • Belder R; Centre for Clinical Transfusion Medicine, Medical Faculty of Tübingen, University of Tübingen, Tübingen, Germany.
  • van den Berg R; Netherlands Thrombosis Foundation, Voorschoten, The Netherlands.
  • Boumans E; Department of Radiology and Nuclear Medicine, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
  • Cannegieter S; Patients' Representative, The Netherlands.
  • Cano-Nigenda V; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Field TS; Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico.
  • Fragata I; Vancouver Stroke Program, Division of Neurology, University of British Columbia, Vancouver, BC, Canada.
  • Heldner MR; Stroke Center, Centro Hospitalar Universitário Lisboa Central, Institute of Anatomy, Faculdade de Medicina, Universidade de Lisboa, and L Lopes Lab, Instituto de Medicina Molecular JLA, Lisbon, Portugal.
  • Hernández-Pérez M; NOVA Medical School, Universidade NOVA de Lisboa, Lisboa, Portugal.
  • Klok FA; Inselspital Bern, University Hospital and University of Bern, Bern, Switzerland.
  • Leker RR; Hospital Germans Trias i Pujol, Badalona, Spain.
  • Lucas-Neto L; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
  • Molad J; Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Nguyen TN; North Lisbon University Hospital Center and Lisbon Medical School, Lisbon, Portugal.
  • Saaltink DJ; Tel Aviv Medical Center, Tel Aviv, Israel.
  • Saposnik G; Boston Medical Center, Boston, MA, United States.
  • Sharma P; Dutch Brain Foundation, The Hague, The Netherlands.
  • Stam J; Stroke Outcomes & Decision Neuroscience Research Unit, University of Toronto, Toronto, ON, Canada.
  • Thijs V; Royal Holloway University of London, London, United Kingdom.
  • van der Vaart M; Department of Neurology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
  • Werring DJ; Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
  • Wong Ramos D; Department of Medicine, The University of Melbourne, Parkville, VIC, Australia.
  • Yaghi S; Dutch Heart Foundation, The Hague, The Netherlands.
  • Yesilot N; UCL Queen Square Institute of Neurology, London, United Kingdom.
  • Tatlisumak T; Portugal AVC-União de Sobreviventes, Familiares e Amigos, Portugal.
  • Putaala J; Brown University, Providence, RI, USA.
  • Jood K; Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Arnold M; Department of Neurology, Sahlgrenska University Hospital and Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Ferro JM; Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Int J Stroke ; 19(6): 599-610, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38494462
ABSTRACT

BACKGROUND:

Due to the rarity of cerebral venous thrombosis (CVT), performing high-quality scientific research in this field is challenging. Providing answers to unresolved research questions will improve prevention, diagnosis, and treatment, and ultimately translate to a better outcome of patients with CVT. We present an international research agenda, in which the most important research questions in the field of CVT are prioritized.

AIMS:

This research agenda has three distinct goals (1) to provide inspiration and focus to research on CVT for the coming years, (2) to reinforce international collaboration, and (3) to facilitate the acquisition of research funding. SUMMARY OF REVIEW This international research agenda is the result of a research summit organized by the International Cerebral Venous Thrombosis Consortium in Amsterdam, the Netherlands, in June 2023. The summit brought together 45 participants from 15 countries including clinical researchers from various disciplines, patients who previously suffered from CVT, and delegates from industry and non-profit funding organizations. The research agenda is categorized into six pre-specified themes (1) epidemiology and clinical features, (2) life after CVT, (3) neuroimaging and diagnosis, (4) pathophysiology, (5) medical treatment, and (6) endovascular treatment. For each theme, we present two to four research questions, followed by a brief substantiation per question. The research questions were prioritized by the participants of the summit through consensus discussion.

CONCLUSIONS:

This international research agenda provides an overview of the most burning research questions on CVT. Answering these questions will advance our understanding and management of CVT, which will ultimately lead to improved outcomes for CVT patients worldwide.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Venous Thrombosis / Intracranial Thrombosis Limits: Humans Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Venous Thrombosis / Intracranial Thrombosis Limits: Humans Language: En Year: 2024 Type: Article